|
|
| |
|
|
| |
Rave Lite for Early and Late-Stage Trials
A cost effective and focused version of Rave EDC that supports data capture, data management, and basic data analysis for Phase I and Phase IV studies.
|
|
| |
|
|
|
| |
|
|
| |
Medidata understands firsthand that different trials require different solutions. To better suit the nuances of each trial's budget and requirements, Medidata offers a new approach to addressing the specific needs of each study. |
|
| |
|
|
|
| |
The Rave EDC you already know and trust on more flexible terms
With Rave Lite, Phase I and Phase IV studies gain an efficient electronic clinical data capture, management, and analysis solution with a tailored pricing model—regardless of company size, therapeutic focus, or pipeline.
|
 |
|
| |
|
|
|
| |
 |
Protect your investment in a new compound
Achieve your goals with faster and more efficient study builds that ensure your trial starts on schedule. Rave for Early-Stage Trials enables you to transition rapidly and seamlessly from Phase I to planning the next phase of your trial.
|
|
| |
|
|
|
| |
Achieve fast and efficient study builds; drive effective patient recruitment and retention
Phase IV, observational, or post-marketing surveillance studies aim to observe and record data, behaviors and outcomes in a real-world setting. Rave for Late-Stage Trials’ tailored pricing model scales according to your needs, reducing unnecessary complexities and accelerating your study timeline.
|
 |
|
| |
|
|
|
| |
 |
Everest Group EDC Report
Medidata is recognized as the industry leader in Everest Group’s 2024 Peak Matrix Life Sciences Electronic Data Capture.
|
|
| |
|
|
|
| © 2024 Medidata Solutions. All rights reserved.
350 Hudson St, 9th Floor, New York, NY 10014
1-866-MEDIDATA (633-4328)
|
|
|
|
